Did you know about a quarter of lung cancer patients will also develop brain metastases?
Mark your calendars – November is Lung Cancer Awareness Month. To help highlight this important topic, the ABTA is partnering with LUNGevity to share facts about the risks and impact of brain metastases in lung cancer.
Metastatic brain tumors are the most common brain tumor type among adults. Between 100,000 – 200,000 adults are diagnosed each year in the U.S., and lung cancer is one of the leading contributors to brain metastases.
The ABTA offers free educational brochures, support services and tools to educate and empower those affected by a metastatic brain tumor.
Here are a few quick facts about brain metastasis in lung cancer:
- Approximately 25% of lung cancer patients will develop brain metastases.
- Brain metastases are usually found about four months after an initial lung cancer diagnosis.
- Lung cancer patients are more likely to have multiple brain metastases.
This November, the ABTA is hosting a free webinar, in partnership with LUNGevity, on “How Metastatic Brain Tumors Affect Your Lung Cancer Care.” Join us Thursday, November 10 at 1 p.m. CT.
Lung cancer patients, caregivers and survivors are invited to learn about risk factors, signs and symptoms, treatment options, and management of brain metastases in lung cancer from a panel of multidisciplinary experts. The webinar will also include a Q&A session with speakers.
Click below to watch the recording.
Jessie Schlacks
Jessie is Managing Editor of the bi-monthly e-newsletter MindMatters. Submit story ideas or questions to jschlacks@abta.org.
